Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination

被引:18
|
作者
Forns, Xavier [1 ,2 ]
Colom, Joan [3 ]
Garcia-Retortillo, Montse [4 ]
Carles Quer, Joan [5 ]
Lens, Sabela [1 ,2 ]
Martro, Elisa [6 ,7 ]
Dominguez-Hernandez, Raquel [8 ]
Angel Casado, Miguel [8 ]
Buti, Maria [2 ,9 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain
[2] Inst Carlos III, CIBERehd, Barcelona, Spain
[3] Agcy Publ Hlth Catalonia, Programme Prevent Control & Treatment HIV STIs &, Programme Subst Abuse, Barcelona, Spain
[4] Hosp Mar, Dept Gastroenterol, Liver Sect, Barcelona, Spain
[5] Univ Hosp Joan XXIII, Gastroenterol Dept, Tarragona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, Microbiol Dept, Lab Clin Metropolitana Nord, Badalona, Spain
[7] Inst Salud Carlos III, Biomed Res Networking Ctr Epidemiol & Publ Hlth C, Madrid, Spain
[8] Pharmacoecon & Amp Outcomes Res Iberia PORIB, Madrid, Spain
[9] Hosp Univ Vall dHebron, Internal Med Dept, Liver Unit, Barcelona, Spain
关键词
addiction centres; cascade of care; drug users; harm reduction services; hepatitis C virus; linkage-to-care; test and treat;
D O I
10.1111/jvh.13634
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
According to WHO goals, the elimination of Hepatitis C Virus (HCV) by 2030 requires enhancing and simplifying HCV testing. Our aim was to create a model to assess and compare different strategies for HCV testing, linkage to care and treatment among people who access harm reduction centres (HRC) and Addiction Centres in Catalonia. A decision tree model was designed to evaluate two strategies: Hepatitis C Point-of-care (POC) "test and treat", at the community versus standard-of-care (SOC), in which HCV testing was performed at community and therapy at the hospital. Both strategies were assessed separately in HRCs (6,878 users) and Addiction Centres (13,778 users). with a time horizon of 18 months. Healthcare outcomes were HCV testing, linkage to care, treatment outcomes and reinfection rate. HCV testing was performed in 3,178 (46%) of the HRC users. Compared with SOC, POC increased access to treatment by 57% (63% vs. 6%). SVR rates were 64% in POC vs. 23% in SOC. Reinfection rates were 21% with POC compared to 24% with SOC. With POC, losses to follow-up were reduced by 41%. In the Addiction Centres, 12,566 users (91%) were screened using the two strategies. Compared to the SOC, POC increased access to treatment and linkage to care by 19% along with SVR at the same rate. Reinfection rates decreased by 6%. Thus, the implementation of a POC "test and treat" strategy at HRCs and Addiction Centres has shown to be an effective public health strategy to help eliminating HCV in accordance with WHO goal.
引用
收藏
页码:227 / 230
页数:4
相关论文
共 50 条
  • [1] POINT-OF-CARE HEPATITIS C TESTING AND TREATING STRATEGY IN PEOPLE WHO INJECT DRUGS IN HARM REDUCTION AND ADDICTION CENTERS FOR HEPATITIS C ELIMINATION
    Forns, Xavier
    Colom, Joan
    Garcia-Retortillo, Montserrat
    Quer, Joan Cartes
    Lens, Sabela
    Dominguez-Hernandez, Raquel
    Angel Casado, Miguel
    Buti Ferret, Maria Asuncion
    HEPATOLOGY, 2020, 72 : 402A - 403A
  • [2] Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination Effort
    Yew, Kuo Chao
    Sim, Alyssa Shin Yee
    Hawkins, Robert
    Acharyya, Sanchalika
    Wong, Gerard Daquan
    Wong, Samuel Wei Chong
    Lim, Yuan Heng
    Yang, Wei Lyn
    Lim, Wei-Yen
    Chow, Angela Li Ping
    JOURNAL OF VIRAL HEPATITIS, 2025, 32 (04)
  • [3] Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres
    Morales-Arraez, Dalia
    Hernandez-Bustabad, Alberto
    Medina-Alonso, Maria Jesus
    Santiago-Gutierrez, Luz Goretti
    Garcia-Gil, Sara
    Diaz-Flores, Felicitas
    Perez-Perez, Victor
    Nazco, Julia
    de Rota Martin, Pilar Fernandez
    Gutierrez, Fernando
    Hernandez-Guerra, Manuel
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 94
  • [4] Hepatitis C Point-of-Care Testing in Vulnerable Populations
    Zucker, Donna M.
    Shanmugam, Akshaya
    GASTROENTEROLOGY NURSING, 2016, 39 (06) : 472 - 477
  • [5] Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection
    Stevens, Annabelle
    Lafferty, Lise
    Treloar, Carla
    Cunningham, Evan B.
    Dore, Gregory J.
    Grebely, Jason
    Marshall, Alison D.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2025, 137
  • [6] The Urgent Need to Implement Point-of-Care RNA Testing for Hepatitis C Virus to Support Elimination
    Kapadia, Shashi N.
    Jordan, Ashly E.
    Eckhardt, Benjamin J.
    Perlman, David C.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1235 - 1239
  • [8] The elimination of hepatitis C in the cherokee Nation: the impact of harm reduction
    Mera, Jorge
    Essex, Whitney
    Feder, Molly
    Razavi, Homie
    Razavi-Shearer, Devin
    JOURNAL OF HEPATOLOGY, 2022, 77 : S226 - S227
  • [9] Progress towards hepatitis C elimination: Feasibility and success of a nurse- and harm reduction practitioner-led model of care using rapid point-of-care hepatitis C virus RNA testing at a medically supervised injecting room in Melbourne, Australia
    Macisaac, M.
    Whitton, B.
    Anderson, J.
    Penn, M.
    Weeks, A.
    Cogger, S.
    Elmore, K.
    Pemberton, D.
    Papaluca, T.
    Hellard, M.
    Stoove, M.
    Wilson, D.
    Pedrana, A.
    Doyle, J.
    Clark, N.
    Holmes, J.
    Thompson, A. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 55 - 55
  • [10] Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada
    Broad, Jennifer
    Mason, Kate
    Guyton, Mary
    Lettner, Bernadette
    Matelski, John
    Powis, Jeff
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 80